News
Is Pfizer's Seagen Deal In Jeopardy Amid Antitrust Scrutiny?
Pfizer Inc. (NYSE: PFE) continued its downward trajectory on May 17, following news that the Federal Trade Commission is seeking to block Amgen Inc.’s (NASDAQ: AMGN) planned acquisition of Horizon
Is Pfizer's Seagen Deal In Jeopardy Amid Antitrust Scrutiny?
Pfizer Inc. (NYSE: PFE) continued its downward trajectory on May 17, following news that the Federal Trade Commission is seeking to block Amgen Inc.’s (NASDAQ: AMGN) planned acquisition of Horizon
Tyson Insiders Buy Shares At Multi-Year Low
Tyson shares fell more than 7% following the Q1 earnings report and may fall further, but this opportunity for investors should not be ignored. The results were tepid and the guidance weak, but
Cisco Systems Falls Into The Buy Zone
Shares of Cisco Systems (NASDAQ: CSCO) fell 3% following its Q3 report sending shares into the buy zone. The drop was driven by fears centered on a slowing order book that points to sluggish
Cisco Systems Falls Into The Buy Zone
Shares of Cisco Systems (NASDAQ: CSCO) fell 3% following its Q3 report sending shares into the buy zone. The drop was driven by fears centered on a slowing order book that points to sluggish
Cisco Systems Falls Into The Buy Zone
Shares of Cisco Systems (NASDAQ: CSCO) fell 3% following its Q3 report sending shares into the buy zone. The drop was driven by fears centered on a slowing order book that points to sluggish
Cisco Systems Falls Into The Buy Zone
Shares of Cisco Systems (NASDAQ: CSCO) fell 3% following its Q3 report sending shares into the buy zone. The drop was driven by fears centered on a slowing order book that points to sluggish
Gold Hot Stock entdeckt 1,18 Mio. Unzen Gold. 400% Gold Aktientip im Visier von Barrick Gold ($GOLD) und Newmont ($NEM). Diese Gold-Aktie steigt jetzt 400% nach 1.256% mit den Gold-Aktien von Newmont Corporation (NYSE:NEM) und 4.460% mit den Gold-Akt
Gold Hot Stock entdeckt 1,18 Mio. Unzen Gold. 400% Gold Aktientip im Visier von Barrick Gold ($GOLD) und Newmont ($NEM)
19.05.23
It’s Time To Take Another Bite Of Take-Two Interactive
Take-Two Interactive (NASDAQ: TTWO) had a mixed quarter and gave weak guidance, but the stock is up strongly despite the news. The report was mixed but came with a growth outlook that told the
Zoetis Declares New Dividend, Hinting At Undervaluation
Zoetis (NYSE: ZTS) shareholders may have a new reference point to be excited about, even after witnessing some favorable developments through the company's first quarter 2023 announcements. Even
4ocean und U.S. Polo Assn. erneuern globale Partnerschaft für positive Nachhaltigkeit in den Ozeanen mit dem Ziel, 150.000 Pfund Müll aus den Weltmeeren zu entfernen
Boca Raton, FL / Accesswire / 18. Mai 2023 / 4ocean, eine zweckorientierte B Corp. mit der Mission, die Plastikkrise in den Ozeanen zu bekämpfen, und U.S. Polo Assn., die offizielle Marke der
4ocean and U.S. Polo Assn. Renew Global Ocean-Positive Sustainability Partnership Goal to Remove 150,000 Pounds of Trash from World's Oceans
BOCA RATON, FL / ACCESSWIRE / May 18, 2023 / 4ocean, a purpose-driven B Corp with a mission to end the ocean plastic crisis, in partnership with U.S. Polo Assn., the official brand of the
Good News For Walmart Isn’t So Great For Everybody Else
Walmart (NYSE: WMT) had a better-than-expected quarter and raised its full-year guidance, but the news isn’t as great as it may seem. The gains were driven by isolated segments that confirm
Good News For Walmart Isn’t So Great For Everybody Else
Walmart (NYSE: WMT) had a better-than-expected quarter and raised its full-year guidance, but the news isn’t as great as it may seem. The gains were driven by isolated segments that confirm
Pharma Giants Novartis, Lilly, Merck, and Novo Outperform Market
Big pharmaceutical stocks, including Novartis AG (NYSE: NVS), Eli Lilly & Co. (NYSE: LLY), Merck & Co. (NYSE: MRK), and Novo Nordisk A/S (NYSE: NVO) have been outperforming the broader market
Berry Global, The Backbone Of Consumer Packaging You Should Own
Berry Global Group (NYSE: BERY) is one of those businesses that do not seem to let off the gas pedal, significantly when all other sectors lag in performance. As a result, Berry has been
Vertex Pharmaceuticals Hits Record High on Strong Q1 Earnings
Vertex Pharmaceuticals Inc. (NASDAQ: VRTX), maker of Cystic fibrosis drugs, rallied to a record high on May 2 after a better-than-expected first-quarter earnings report.
Net income of $3.05 a
Vertex Pharmaceuticals Hits Record High on Strong Q1 Earnings
Vertex Pharmaceuticals Inc. (NASDAQ: VRTX), maker of Cystic fibrosis drugs, rallied to a record high on May 2 after a better-than-expected first-quarter earnings report.
Net income of $3.05 a
Vertex Pharmaceuticals Hits Record High on Strong Q1 Earnings
Vertex Pharmaceuticals Inc. (NASDAQ: VRTX), maker of Cystic fibrosis drugs, rallied to a record high on May 2 after a better-than-expected first-quarter earnings report.
Net income of $3.05 a
Copart Auctions, A Little Outlet For America's Car Problems
Shares of Copart (NASDAQ: CPRT) reached an all-time high price of $82.81 in the after-market hours of Wednesday evening, amid monstrous momentum buildup throughout 2022, seemingly continuing into
Copart Auctions, A Little Outlet For America's Car Problems
Shares of Copart (NASDAQ: CPRT) reached an all-time high price of $82.81 in the after-market hours of Wednesday evening, amid monstrous momentum buildup throughout 2022, seemingly continuing into
Copart Auctions, A Little Outlet For America's Car Problems
Shares of Copart (NASDAQ: CPRT) reached an all-time high price of $82.81 in the after-market hours of Wednesday evening, amid monstrous momentum buildup throughout 2022, seemingly continuing into
ServiceNow Serves Up A Reversal, Now!
ServiceNow (NASDAQ: NOW) surprised the market when it announced a massive share repurchase authorization. The authorization was announced at the shareholder event and is worth $1.5 billion. That’s
Analysts Say These 2 Mid-Cap Biotechs Have 2x Potential
On May 15th, mid-cap biotechnology company Sarepta Therapeutics was the big winner in an otherwise quiet day for the Russell 1000 Index. Sarepta jumped more than 30% after an FDA advisory panel
The TJX Companies Inc: A Good Pick for 2023?
The shifting consumer environment has affected the TJX Companies Inc. (NYSE: TJX). Consumers have shifted from discretionary items to staples, trading down from higher-tier retailers to low-price